Literature DB >> 9151339

Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis.

K Oymar1, S Elsayed, R Bjerknes.   

Abstract

The aim of our study was to evaluate the clinical applicability of serum eosinophil cationic protein (ECP), interleukin-5 (IL-5) and total eosinophil counts in childhood asthma and bronchiolitis. These parameters were measured in 44 children aged 12-84 months with moderate and mild asthma during symptomatic and asymptomatic phases of disease. Fifteen of the patients were included at the time of admission to hospital due to an acute asthmatic attack, and ten of these were also examined one month after discharge. None of the patients were treated with glucocorticoids or cromoglycate at any time during the study. Serum ECP was significantly increased in the children with acute asthma compared to children with stable moderate asthma, stable mild asthma, as well as to controls. There was no difference between the groups with stable asthma or between stable asthma and controls, and there was large overlap between all groups of asthmatics and controls. Detectable levels of circulating IL-5 were demonstrated in eight of 15 children with acute asthma, with significantly higher levels in atopic children, whereas all samples from children with stable asthma and controls were negative. The results suggest that even though serum ECP and IL-5 increases during acute asthmatic attacks, these parameters cannot alone be used to discriminate between different groups of young children with stable asthma, nor between asthmatics and healthy controls. In addition, the same parameters of eosinophil inflammation were examined in serum samples from 25 children aged 1-17 months undergoing their first episode of acute bronchiolitis. Children with acute respiratory syncytial virus (RSV) bronchiolitis had significantly higher levels of serum ECP than those with RSV negative disease, whereas the total eosinophil counts were significantly decreased in all patients with acute bronchiolitis. Serum IL-5 was only detected in two children with acute bronchiolitis. The results suggest that the inflammation in RSV bronchiolitis differs from that induced by other viruses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9151339     DOI: 10.1111/j.1399-3038.1996.tb00130.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  6 in total

Review 1.  Early identification of atopy in the prediction of persistent asthma in children.

Authors:  Peter D Sly; Attilio L Boner; Bengt Björksten; Andy Bush; Adnan Custovic; Philippe A Eigenmann; James E Gern; Jorrit Gerritsen; Eckard Hamelmann; Peter J Helms; Robert F Lemanske; Fernando Martinez; Soren Pedersen; Harald Renz; Hugh Sampson; Erika von Mutius; Ulrich Wahn; Patrick G Holt
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

2.  Regulation of the interleukin-5 receptor alpha-subunit on peripheral blood eosinophils from healthy subjects.

Authors:  C Hellman; G Halldén; B Hylander; J Lundahl
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

3.  Reduced lung function both before bronchiolitis and at 11 years.

Authors:  S W Turner; S Young; L I Landau; P N Le Souëf
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

Review 4.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 5.  Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

6.  Comparison of cytokine responses in nasopharyngeal aspirates from children with viral lower respiratory tract infections.

Authors:  Jung Hye Byeon; Jin Chul Lee; Ic Sun Choi; Young Yoo; Sang Hee Park; Ji Tae Choung
Journal:  Acta Paediatr       Date:  2009-01-13       Impact factor: 2.299

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.